|
1
|
Vogel WF, Abdulhussein R and Ford CE:
Sensing extracellular matrix: An update on discoidin domain
receptor function. Cell Signal. 18:1108–1116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Valiathan RR, Marco M, Leitinger B, Kleer
CG and Fridman R: Discoidin domain receptor tyrosine kinases: New
players in cancer progression. Cancer Metastasis Rev. 31:295–321.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shrivastava A, Radziejewski C, Campbell E,
Kovac L, McGlynn M, Ryan TE, Davis S, Goldfarb MP, Glass DJ, Lemke
G and Yancopoulos GD: An orphan receptor tyrosine kinase family
whose members serve as nonintegrin collagen receptors. Mol Cell.
1:25–34. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Playford MP, Butler RJ, Wang XC, Katso RM,
Cooke IE and Ganesan TS: The genomic structure of discoidin
receptor tyrosine kinase. Genome Res. 6:620–627. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hou G, Vogel W and Bendeck MP: The
discoidin domain receptor tyrosine kinase DDR1 in arterial wound
repair. J Clin Invest. 107:727–735. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Quan J, Yahata T, Adachi S, Yoshihara K
and Tanaka K: Identification of receptor tyrosine kinase, discoidin
domain receptor 1 (DDR1), as a potential biomarker for serous
ovarian cancer. Int J Mol Sci. 12:971–982. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakada M, Kita D, Teng L, Pyko IV,
Watanabe T, Hayashi Y and Hamada J: Receptor tyrosine kinases:
Principles and functions in glioma invasion. Adv Exp Med Biol.
986:143–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang SH, Baek HA, Lee HJ, Park HS, Jang
KY, Kang MJ, Lee DG, Lee YC, Moon WS and Chung MJ: Discoidin domain
receptor 1 is associated with poor prognosis of non-small cell lung
carcinomas. Oncol Rep. 24:311–319. 2010.PubMed/NCBI
|
|
9
|
Shimada K, Nakamura M, Ishida E, Higuchi
T, Yamamoto H, Tsujikawa K and Konishi N: Prostate cancer antigen-1
contributes to cell survival and invasion though discoidin receptor
1 in human prostate cancer. Cancer Sci. 99:39–45. 2008.PubMed/NCBI
|
|
10
|
Nemoto T, Ohashi K, Akashi T, Johnson JD
and Hirokawa K: Overexpression of protein tyrosine kinases in human
esophageal cancer. Pathobiology. 65:195–203. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Willenbrock K, Kuppers R, Renne C, Brune
V, Eckerle S, Weidmann E, Bräuninger A and Hansmann ML: Common
features and differences in the transcriptome of large cell
anaplastic lymphoma and classical Hodgkin's lymphoma.
Haematologica. 91:596–604. 2006.PubMed/NCBI
|
|
12
|
Song J, Chen X, Bai J, Liu Q, Li H, Xie J,
Jing H and Zheng J: Discoidin domain receptor 1 (DDR1), a promising
biomarker, induces epithelial to mesenchymal transition in renal
cancer cells. Tumour Biol. 37:11509–11521. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Toy KA, Valiathan RR, Núñez F, Kidwell KM,
Gonzalez ME, Fridman R and Kleer CG: Tyrosine kinase discoidin
domain receptors DDR1 and DDR2 are coordinately deregulated in
triple-negative breast cancer. Breast Cancer Res Treat. 150:9–18.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen Q, Cicinnati VR, Zhang X, Iacob S,
Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G and
Beckebaum S: Role of microRNA-199a-5p and discoidin domain receptor
1 in human hepatocellular carcinoma invasion. Mol Cancer.
9:2272010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maskarinec G, Pagano IS, Little MA, Conroy
SM, Park SY and Kolonel LN: Mammographic density as a predictor of
breast cancer survival: The Multiethnic Cohort. Breast Cancer Res.
15:R72013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tice JA, O'Meara ES, Weaver DL, Vachon C,
Ballard-Barbash R and Kerlikowske K: Benign breast disease,
mammographic breast density and the risk of breast cancer. J Natl
Cancer Inst. 105:1043–1049. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ameli F, Rose IM and Masir N: Expression
of DDR1 and DVL1 in invasive ductal and lobular breast carcinoma
does not correlate with histological type, grade and hormone
receptor status. Asian Pac J Cancer Prev. 16:2385–2390. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Egeblad M, Rasch MG and Weaver VM: Dynamic
interplay between the collagen scaffold and tumor evolution.
Current Opin Cell Biol. 22:697–706. 2010. View Article : Google Scholar
|
|
20
|
Vogel W, Gish GD, Alves F and Pawson T:
The discoidin domain receptor tyrosine kinases are activated by
collagen. Mol Cell. 1:13–23. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leitinger B: Molecular analysis of
collagen binding by the human discoidin domain receptors, DDR1 and
DDR2. Identification of collagen binding sites in DDR2. J Biol
Chem. 278:16761–16769. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abdulhussein R, McFadden C, Fuentes-Prior
P and Vogel WF: Exploring the collagen-binding site of the DDR1
tyrosine kinase receptor. J Biol Chem. 279:31462–31470. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Konitsiotis AD, Raynal N, Bihan D,
Hohenester E, Farndale RW and Leitinger B: Characterization of high
affinity binding motifs for the discoidin domain receptor DDR2 in
collagen. J Biol Chem. 283:6861–6868. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu H, Raynal N, Stathopoulos S, Myllyharju
J, Farndale RW and Leitinger B: Collagen binding specificity of the
discoidin domain receptors: Binding sites on collagens II and III
and molecular determinants for collagen IV recognition by DDR1.
Matrix Biol. 30:16–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leitinger B: Transmembrane collagen
receptors. Annu Rev Cell Dev Biol. 27:265–290. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
L'Hote CG, Thomas PH and Ganesan TS:
Functional analysis of discoidin domain receptor 1: Effect of
adhesion on DDR1 phosphorylation. FASEB J. 16:234–236. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koo DH, McFadden C, Huang Y, Abdulhussein
R, Friese-Hamim M and Vogel WF: Pinpointing
phosphotyrosine-dependent interactions downstream of the collagen
receptor DDR1. FEBS Lett. 580:15–22. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang CZ, Su HW, Hsu YC, Shen MR and Tang
MJ: A discoidin domain receptor 1/SHP-2 signaling complex inhibits
alpha2beta1-integrin-mediated signal transducers and activators of
transcription 1/3 activation and cell migration. Mol Biol Cell.
17:2839–2852. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lemeer S, Bluwstein A, Wu Z, Leberfinger
J, Müller K, Kramer K and Kuster B: Phosphotyrosine mediated
protein interactions of the discoidin domain receptor 1. J
Proteomics. 75:3465–3477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nascimento AF, Raut CP and Fletcher CD:
Primary angiosarcoma of the breast: Clinicopathologic analysis of
49 cases, suggesting that grade is not prognostic. Am J Surg
Pathol. 32:1896–1904. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Petridis C, Brook MN, Shah V, Kohut K,
Gorman P, Caneppele M, Levi D, Papouli E, Orr N, Cox A, et al:
Genetic predisposition to ductal carcinoma in situ of the breast.
Breast Cancer Res. 18:222016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Turashvili G, Bouchal J, Baumforth K, Wei
W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J,
Srovnal J, et al: Novel markers for differentiation of lobular and
ductal invasive breast carcinomas by laser microdissection and
microarray analysis. BMC Cancer. 7:552007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Spaderna S, Schmalhofer O, Wahlbuhl M,
Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A,
et al: The transcriptional repressor ZEB1 promotes metastasis and
loss of cell polarity in cancer. Cancer Res. 68:537–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dejmek J, Dib K, Jonsson M and Andersson
T: Wnt-5a and G-protein signaling are required for collagen-induced
DDR1 receptor activation and normal mammary cell adhesion. Int J
Cancer. 103:344–351. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Islam N, Kwon SC, Senie R and Kathuria N:
Breast and cervical cancer screening among South Asian women in New
York city. J Immigr Minor Health. 8:211–221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shipitsin M, Campbell LL, Argani P,
Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T,
Serebryiskaya T, Beroukhim R, Hu M, et al: Molecular definition of
breast tumor heterogeneity. Cancer Cell. 11:259–273. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Blick T, Hugo H, Widodo E, Waltham M,
Pinto C, Mani SA, Weinberg RA, Neve RM, Lenburg ME and Thompson EW:
Epithelial mesenchymal transition traits in human breast cancer
cell lines parallel the CD44 (hi/)CD24 (lo/-) stem cell phenotype
in human breast cancer. J Mammary Gland Biol Neoplasia. 15:235–252.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sheen YY, Kim MJ, Park SA, Park SY and Nam
JS: Targeting the transforming growth factor-β signaling in cancer
therapy. Biomol Ther (Seoul). 21:323–331. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Savagner P: Leaving the neighborhood:
molecular mechanisms involved during epithelial-mesenchymal
transition. Bioessays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hay ED: An overview of
epithelio-mesenchymal transformation. Acta Anat (Basel). 154:8–20.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Savagner P, Boyer B, Valles AM, Jouanneau
J and Thiery JP: Modulations of the epithelial phenotype during
embryogenesis and cancer progression. Cancer Treat Res. 71:229–249.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Maeyama M, Koga H, Selvendiran K,
Yanagimoto C, Hanada S, Taniguchi E, Kawaguchi T, Harada M, Ueno T
and Sata M: Switching in discoid domain receptor expressions in
SLUG-induced epithelial-mesenchymal transition. Cancer.
113:2823–2831. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Taube JH, Herschkowitz JI, Komurov K, Zhou
AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, et
al: Core epithelial-to-mesenchymal transition interactome
gene-expression signature is associated with claudin-low and
metaplastic breast cancer subtypes. Proc Natl Acad Sci USA.
107:15449–15454. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Koh M, Woo Y, Valiathan RR, Jung HY, Park
SY, Kim YN, Kim HR, Fridman R and Moon A: Discoidin domain receptor
1 is a novel transcriptional target of ZEB1 in breast epithelial
cells undergoing H-Ras-induced epithelial to mesenchymal
transition. Int J Cancer. 136:E508–E520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yeh YC, Wu CC, Wang YK and Tang MJ: DDR1
triggers epithelial cell differentiation by promoting cell adhesion
through stabilization of E-cadherin. Mol Biol Cell. 22:940–953.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hidalgo-Carcedo C, Hooper S, Chaudhry SI,
Williamson P, Harrington K, Leitinger B and Sahai E: Collective
cell migration requires suppression of actomyosin at cell-cell
contacts mediated by DDR1 and the cell polarity regulators Par3 and
Par6. Nat Cell Biol. 13:49–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Eswaramoorthy R, Wang CK, Chen WC, Tang
MJ, Ho ML, Hwang CC, Wang HM and Wang CZ: DDR1 regulates the
stabilization of cell surface E-cadherin and E-cadherin-mediated
cell aggregation. J Cell Physiol. 224:387–397. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang L, Devarajan E, He J, Reddy SP and
Dai JL: Transcription repressor activity of spleen tyrosine kinase
mediates breast tumor suppression. Cancer Res. 65:10289–10297.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kamohara H, Yamashiro S, Galligan C and
Yoshimura T: Discoidin domain receptor 1 isoform-a (DDR1alpha)
promotes migration of leukocytes in three-dimensional collagen
lattices. FASEB J. 15:2724–2726. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jonsson M and Andersson T: Repression of
Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and
migration of mammary cells. J Sci. 114:2043–2053. 2001.
|
|
53
|
Hou G, Vogel WF and Bendeck MP: Tyrosine
kinase activity of discoidin domain receptor 1 is necessary for
smooth muscle cell migration and matrix metalloproteinase
expression. Circ Res. 90:1147–1149. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Neuhaus B, Bühren S, Böck B, Alves F,
Vogel WF and Kiefer F: Migration inhibition of mammary epithelial
cells by Syk is blocked in the presence of DDR1 receptors. Cell Mol
Life Sci. 68:3757–3770. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Dejmek J, Leandersson K, Manjer J,
Bjartell A, Emdin SO, Vogel WF, Landberg G and Andersson T:
Expression and signaling activity of Wnt-5a/discoidin domain
receptor-1 and Syk plays distinct but decisive roles in breast
cancer patient survival. Clin Cancer Res. 11:520–528.
2005.PubMed/NCBI
|
|
56
|
Castro-Sanchez L, Soto-Guzman A,
Guaderrama-Diaz M, Cortes-Reynosa P and Salazar EP: Role of DDR1 in
the gelatinases secretion induced by native type IV collagen in
MDA-MB-231 breast cancer cells. Clin Exp Metastasis. 28:463–477.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Huang Y, Arora P, McCulloch CA and Vogel
WF: The collagen receptor DDR1 regulates cell spreading and
motility by associating with myosin IIA. J Cell Sci. 122:1637–1646.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Castro-Sanchez L, Soto-Guzman A,
Navarro-Tito N, Martinez-Orozco R and Salazar EP: Native type IV
collagen induces cell migration through a CD9 and DDR1-dependent
pathway in MDA-MB-231 breast cancer cells. Eur J Cell Biol.
89:843–852. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hansen C, Greengard P, Nairn AC, Andersson
T and Vogel WF: Phosphorylation of DARPP-32 regulates breast cancer
cell migration downstream of the receptor tyrosine kinase DDR1. Exp
Cell Res. 312:4011–4018. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Dierick H and Bejsovec A: Cellular
mechanisms of wingless/Wnt signal transduction. Curr Top Dev Biol.
43:153–190. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Pruitt MM, Letcher EJ, Chou HC, Bastin BR
and Schneider SQ: Expression of the wnt gene complement in a
spiral-cleaving embryo and trochophore larva. Int J Dev Biol.
58:563–573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Dale TC: Signal transduction by the Wnt
family of ligands. Biochem J. 329:209–223. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Brennan KR and Brown AM: Wnt proteins in
mammary development and cancer. J Mammary Gland Biol Neoplasia.
9:119–131. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Katoh M: WNT/PCP signaling pathway and
human cancer (Review). Oncol Rep. 14:1583–1588. 2005.PubMed/NCBI
|
|
65
|
Yang Y: Wnt signaling in development and
disease. Cell Biosci. 2:142012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Roarty K and Serra R: Wnt5a is required
for proper mammary gland development and TGF-beta-mediated
inhibition of ductal growth. Development. 134:3929–3939. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yoshida D and Teramoto A: Enhancement of
pituitary adenoma cell invasion and adhesion is mediated by
discoidin domain receptor-1. J Neurooncol. 82:29–40. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ram R, Lorente G, Nikolich K, Urfer R,
Foehr E and Nagavarapu U: Discoidin domain receptor-1a (DDR1a)
promotes glioma cell invasion and adhesion in association with
matrix metalloproteinase-2. J Neurooncol. 76:239–248. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yamanaka R, Arao T, Yajima N, Tsuchiya N,
Homma J, Tanaka R, Sano M, Oide A, Sekijima M and Nishio K:
Identification of expressed genes characterizing long-term survival
in malignant glioma patients. Oncogene. 25:5994–6002. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Assent D, Bourgot I, Hennuy B, Geurts P,
Noël A, Foidart JM and Maquoi E: A Membrane-Type-1 Matrix
Metalloproteinase (MT1-MMP)-discoidin domain receptor 1 axis
regulates collagen-induced apoptosis in breast cancer cells. PLoS
One. 10:e01160062015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Roberts ME, Magowan L, Hall IP and Johnson
SR: Discoidin domain receptor 1 regulates bronchial epithelial
repair and matrix metalloproteinase production. Eur Respir J.
37:1482–1493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Dang N, Hu J, Liu X, Li X, Ji S, Zhang W,
Su J, Lu F, Yang A, Han H, et al: CD167 acts as a novel
costimulatory receptor in T-cell activation. J Immunother.
32:773–784. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Vogel WF, Aszódi A, Alves F and Pawson T:
Discoidin domain receptor 1 tyrosine kinase has an essential role
in mammary gland development. Mol Cell Biol. 21:2906–2917. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Curat CA and Vogel WF: Discoidin domain
receptor 1 controls growth and adhesion of mesangial cells. J Am
Soc Nephrol. 13:2648–2656. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Franco C, Ahmad PJ, Hou G, Wong E and
Bendeck MP: Increased cell and matrix accumulation during
atherogenesis in mice with vessel wall-specific deletion of
discoidin domain receptor 1. Circ Res. 106:1775–1783. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ambrogio C, Gomez-Lopez G, Falcone M,
Vidal A, Nadal E, Crosetto N, Blasco RB, Fernández-Marcos PJ,
Sánchez-Céspedes M, Ren X, et al: Combined inhibition of DDR1 and
Notch signaling is a therapeutic strategy for KRAS-driven lung
adenocarcinoma. Nat Med. 22:270–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Duncan JS, Whittle MC, Nakamura K, Abell
AN, Midland AA, Zawistowski JS, Johnson NL, Granger DA, Jordan NV,
Darr DB, et al: Dynamic reprogramming of the kinome in response to
targeted MEK inhibition in triple-negative breast cancer. Cell.
149:307–321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ongusaha PP, Kim JI, Fang L, Wong TW,
Yancopoulos GD, Aaronson SA and Lee SW: p53 induction and
activation of DDR1 kinase counteract p53-mediated apoptosis and
influence p53 regulation through a positive feedback loop. EMBO J.
22:1289–1301. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Fanale M: Activated DDR1 increases RS cell
survival. Blood. 122:4152–4154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Das S: Discoidin domain receptor 1
receptor tyrosine kinase induces cyclooxygenase-2 and promotes
chemoresistance through nuclear factor-B pathway activation. Cancer
Res. 66:8123–8130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Rix U, Hantschel O, Duernberger G, Rix
Remsing LL, Planyavsky M, Fernbach NV, Kaupe I, Bennett KL, Valent
P, Colinge J, et al: Chemical proteomic profiles of the BCR-ABL
inhibitors imatinib, nilotinib and dasatinib, reveal novel kinase
and nonkinase targets. Blood. 110:4055–4063. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Bantscheff M, Eberhard D, Abraham Y,
Bastuck S, Boesche M, Hobson S, Mathieson T, Perrin J, Raida M, Rau
C, et al: Quantitative chemical proteomics reveals mechanisms of
action of clinical ABL kinase inhibitors. Nat Biotechnol.
25:1035–1044. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Barker KT, Martindale JE, Mitchell PJ,
Kamalati T, Page MJ, Phippard DJ, Dale TC, Gusterson BA and
Crompton MR: Expression patterns of the novel receptor-like
tyrosine kinase, Ddr, in human breast-tumors. Oncogene. 10:569–575.
1995.PubMed/NCBI
|
|
84
|
Cancer Genome Atlas Network: Comprehensive
molecular portraits of human breast tumours. Nature. 490:61–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Turashvilia G, Bouchala J, Ehrmanna J,
Kolara Z, Fridmanb E and Skardaa J: Novel immunohistochemical
markers for the differentiation of lobular and ductal invasive
breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech
Repub. 151:59–64. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Maquoi E, Assent D, Detilleux J, Pequeux
C, Foidart JM and Noël A: MT1-MMP protects breast carcinoma cells
against type I collagen-induced apoptosis. Oncogene. 31:480–493.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Juin A, Di Martino J, Leitinger B, Henriet
E, Gary AS, Paysan L, Bomo J, Baffet G, Gauthier-Rouvière C,
Rosenbaum J, et al: Discoidin domain receptor 1 controls linear
invadosome formation via a Cdc42-Tuba pathway. J Cell Biol.
207:517–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
